TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours

被引:93
|
作者
Griewank, K. G. [1 ]
Murali, R. [2 ,3 ]
Schilling, B. [1 ]
Scholz, S. [4 ]
Sucker, A. [1 ]
Song, M. [1 ]
Suesskind, D. [5 ]
Grabellus, F. [6 ]
Zimmer, L. [1 ]
Hillen, U. [1 ]
Steuhl, K-P [4 ]
Schadendorf, D. [1 ]
Westekemper, H. [4 ]
Zeschnigk, M. [7 ]
机构
[1] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, D-45147 Essen, Germany
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[4] Univ Duisburg Essen, Univ Hosp, Dept Ophthalmol, D-45147 Essen, Germany
[5] Univ Tubingen Hosp, Dept Ophthalmol, D-72076 Tubingen, Germany
[6] Univ Duisburg Essen, Univ Hosp, Inst Pathol & Neuropathol, D-45147 Essen, Germany
[7] Univ Duisburg Essen, Univ Hosp, Inst Human Genet, D-45147 Essen, Germany
关键词
melanoma; dermatology; telomerase; ophthalmology; cancer genetics; MELANOCYTIC LESIONS; SOMATIC MUTATIONS; BRAF MUTATIONS; HUMAN CANCER; GENE; CLASSIFICATION;
D O I
10.1038/bjc.2013.312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Recently, activating mutations in the TERT promoter were identified in cutaneous melanoma. We tested a cohort of ocular melanoma samples for similar mutations. Methods: The TERT promoter region was analysed by Sanger sequencing in 47 uveal (ciliary body or choroidal) melanomas and 38 conjunctival melanomas. Results: Mutations of the TERT promoter were not identified in uveal melanomas, but were detected in 12 (32%) conjunctival melanomas. Mutations had a UV signature and were identical to those found in cutaneous melanoma. Conclusion: Mutations of TERT promoter with UV signatures are frequent in conjunctival melanomas and favour a pathogenetic kinship with cutaneous melanomas. Absence of these mutations in uveal melanomas emphasises their genetic distinction from cutaneous and conjunctival melanomas.
引用
收藏
页码:497 / 501
页数:5
相关论文
共 50 条
  • [41] POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
    Potrony, M.
    Puig-Butille, J. A.
    Ribera-Sola, M.
    Iyer, V
    Robles-Espinoza, C. D.
    Aguilera, P.
    Carrera, C.
    Malvehy, J.
    Badenas, C.
    Landi, M. T.
    Adams, D. J.
    Puig, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (01) : 105 - 113
  • [42] Absence of the alternative lengthening of telomeres phenotype and low prevalence of TERT promoter mutations in ependymal tumours
    Hewer, E.
    Bruegger, F.
    Marinoni, I.
    Dettmer, M.
    VIRCHOWS ARCHIV, 2015, 467 : S38 - S39
  • [43] TERT promoter mutations associate with MC1R variants in melanoma patients
    Nagore, Eduardo
    Reyes-Garcia, Diana
    Heidenreich, Barbara
    Garcia-Casado, Zaida
    Requena, Celia
    Kumar, Rajiv
    PIGMENT CELL & MELANOMA RESEARCH, 2017, 30 (02) : 273 - 275
  • [44] TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysis
    Gandini, Sara
    Zanna, Ines
    De Angelis, Simone
    Palli, Domenico
    Raimondi, Sara
    Ribero, Simone
    Masala, Giovanna
    Suppa, Mariano
    Bellerba, Federica
    Corso, Federica
    Nezi, Luigi
    Nagore, Eduardo
    Caini, Saverio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
  • [45] Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression
    Piscuoglio, Salvatore
    Ng, Charlotte K. Y.
    Murray, Melissa
    Burke, Kathleen A.
    Edelweiss, Marcia
    Geyer, Felipe C.
    Macedo, Gabriel S.
    Inagaki, Akiko
    Papanastasiou, Anastasios D.
    Martelotto, Luciano G.
    Marchio, Caterina
    Lim, Raymond S.
    Ioris, Rafael A.
    Nahar, Pooja K.
    De Bruijn, Ino
    Smyth, Lillian
    Akram, Muzaffar
    Ross, Dara
    Petrini, John H.
    Norton, Larry
    Solit, David B.
    Baselga, Jose
    Brogi, Edi
    Ladanyi, Marc
    Weigelt, Britta
    Reis-Filho, Jorge S.
    JOURNAL OF PATHOLOGY, 2016, 238 (04): : 508 - 518
  • [46] GNAQ and PMS1 Mutations Associated with Uveal Melanoma, Ocular Surface Melanosis, and Nevus of Ota
    Toomey, Christopher B.
    Fraser, Kyle
    Thorson, John A.
    Goldbaum, Michael H.
    Lin, Jonathan H.
    OCULAR ONCOLOGY AND PATHOLOGY, 2018, 5 (04) : 267 - 272
  • [47] MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours
    Diego A Garcia-Dios
    Dina Levi
    Vandna Shah
    Cheryl Gillett
    Michael A Simpson
    Andrew Hanby
    Ian Tomlinson
    Elinor J Sawyer
    British Journal of Cancer, 2018, 118 : 277 - 284
  • [48] MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours
    Garcia-Dios, Diego A.
    Levi, Dina
    Shah, Vandna
    Gillett, Cheryl
    Simpson, Michael A.
    Hanby, Andrew
    Tomlinson, Ian
    Sawyer, Elinor J.
    BRITISH JOURNAL OF CANCER, 2018, 118 (02) : 277 - 284
  • [49] Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness
    Macerola, Elisabetta
    Loggini, Barbara
    Giannini, Riccardo
    Garavello, Giulia
    Giordano, Mirella
    Proietti, Agnese
    Niccoli, Cristina
    Basolo, Fulvio
    Fontanini, Gabriella
    VIRCHOWS ARCHIV, 2015, 467 (02) : 177 - 184
  • [50] Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness
    Elisabetta Macerola
    Barbara Loggini
    Riccardo Giannini
    Giulia Garavello
    Mirella Giordano
    Agnese Proietti
    Cristina Niccoli
    Fulvio Basolo
    Gabriella Fontanini
    Virchows Archiv, 2015, 467 : 177 - 184